2020
Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials
Brault MA, Spiegelman D, Abdool Karim SS, Vermund SH. Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials. Current HIV/AIDS Reports 2020, 17: 249-258. PMID: 32297219, PMCID: PMC7260110, DOI: 10.1007/s11904-020-00492-4.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Retroviral AgentsClinical Trials as TopicCounselingFemaleHIV InfectionsHumansIncidenceKenyaMaleMass ScreeningSouth AfricaUgandaZambia
2010
Addressing Research Priorities for Prevention of HIV Infection in the United States
Vermund SH, Hodder SL, Justman JE, Koblin BA, Mastro TD, Mayer KH, Wheeler DP, Sadr W. Addressing Research Priorities for Prevention of HIV Infection in the United States. Clinical Infectious Diseases 2010, 50: s149-s155. PMID: 20397942, PMCID: PMC2862583, DOI: 10.1086/651485.Peer-Reviewed Original ResearchMeSH KeywordsBiomedical ResearchClinical Trials as TopicCommunicable Disease ControlEthnicityFemaleHIV InfectionsHomosexuality, MaleHumansMaleResearchRisk FactorsUnited StatesWomenConceptsHIV infectionHuman immunodeficiency virusHispanic womenHIV Prevention Trials NetworkNew HIV infectionsClinical Trials GroupName-based reportingHigh rateImmunodeficiency virusAIDS diagnosisTrial groupUS womenInfected personsPrevention estimatesUS populationHealth messagesEthnic minority populationsTrials NetworkDisease controlInfectionWhite womenWomenPreventionNational InstituteMen
2009
HIV-prevention science at a crossroads: advances in reducing sexual risk
Vermund SH, Allen KL, Karim QA. HIV-prevention science at a crossroads: advances in reducing sexual risk. Current Opinion In HIV And AIDS 2009, 4: 266-273. PMID: 19532063, PMCID: PMC2995247, DOI: 10.1097/coh.0b013e32832c91dd.Peer-Reviewed Original ResearchMeSH KeywordsAfricaClinical Trials as TopicFemaleHIV InfectionsHumansMaleRisk ManagementRisk Reduction BehaviorConceptsRandomized clinical trialsSexual transmissionPrevention strategiesEvidence-based prevention strategiesMale circumcision trialHIV prevention scienceNew prevention toolsSpread of HIVStructural risk factorsPRO 2000Circumcision trialHIV incidenceSyndromic managementRisk factorsClinical trialsMicrobicide trialsPrevention interventionsHIVPrevention benefitsSexual riskPrevention toolTrialsCombination strategiesMore yearsGlobal pandemicWillingness to Be Circumcised for Preventing HIV among Chinese Men Who Have Sex with Men
Ruan Y, Qian HZ, Li D, Shi W, Li Q, Liang H, Yang Y, Luo F, Vermund SH, Shao Y. Willingness to Be Circumcised for Preventing HIV among Chinese Men Who Have Sex with Men. AIDS Patient Care And STDs 2009, 23: 315-321. PMID: 19335172, PMCID: PMC2743100, DOI: 10.1089/apc.2008.0199.Peer-Reviewed Original ResearchConceptsClinical trialsChinese MSMChinese menMale circumcisionEffectiveness of circumcisionLack of historyUncircumcised MSMHIV acquisitionHIV/Genital hygieneAdult circumcisionFree medical servicesTight foreskinSide effectsSexual partnersInfection riskMSMCircumcisionPreventing HIVMedical servicesTrialsMenHeterosexual menCommunity educationSexHIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial
Kapina M, Reid C, Roman K, Cyrus-Cameron E, Kwiecien A, Weiss S, Vermund SH. HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial. Sexually Transmitted Diseases 2009, 36: 129-133. PMID: 19174729, PMCID: PMC2889146, DOI: 10.1097/olq.0b013e318190191d.Peer-Reviewed Original ResearchConceptsHigh HIV prevalenceHIV prevalenceHIV incidenceIncidence rateHighest age-specific prevalenceHuman immunodeficiency virus (HIV) incidencePreparedness studiesBaseline HIV prevalenceRisk reduction counselingAge-specific prevalenceHIV incidence ratesMicrobicide clinical trialsWomen yearsSexual behavioral characteristicsPopulation of womenSame study proceduresGeneral population sampleHIV acquisitionReduction counselingEligible womenHIV/Infection testingRisk factorsClinical trialsPregnancy rate
2007
Use of Traditional Medicine among Pregnant Women in Lusaka, Zambia
Banda Y, Chapman V, Goldenberg RL, Stringer JS, Culhane JF, Sinkala M, Vermund SH, H. B. Use of Traditional Medicine among Pregnant Women in Lusaka, Zambia. Journal Of Alternative And Complementary Medicine 2007, 13: 123-128. PMID: 17309386, DOI: 10.1089/acm.2006.6225.Peer-Reviewed Original ResearchMeSH KeywordsAdultClinical Trials as TopicFemaleHealth BehaviorHealth Knowledge, Attitudes, PracticeHIV InfectionsHumansMaternal BehaviorMaternal Health ServicesMedicine, African TraditionalPatient Acceptance of Health CarePregnancyPregnancy Complications, InfectiousPrevalenceSeroepidemiologic StudiesSurveys and QuestionnairesZambiaConceptsPregnant womenTraditional healersTraditional medicineHuman immunodeficiency virus (HIV) prevention strategiesWorse medical careHealth care providersTraditional medicine usePublic health systemAntiretroviral regimensCurrent pregnancyMedical regimenHIV transmissionMedicine useHIV knowledgeClinical trialsPostpartum questionnaireCare providersPrevention strategiesSex partnersMedical carePrior useHealth systemDry sexPregnancyWomen
2006
Correlates of Syphilis Seroreactivity Among Pregnant Women: The HIVNET 024 Trial in Malawi, Tanzania, and Zambia
Potter D, Goldenberg RL, Read JS, Wang J, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH. Correlates of Syphilis Seroreactivity Among Pregnant Women: The HIVNET 024 Trial in Malawi, Tanzania, and Zambia. Sexually Transmitted Diseases 2006, 33: 604-609. PMID: 16601659, PMCID: PMC2743105, DOI: 10.1097/01.olq.0000216029.00424.ae.Peer-Reviewed Original ResearchConceptsSub-Saharan African settingHistory of stillbirthCross-sectional studyMultisite clinical trialSyphilis preventionSyphilis seroprevalenceSyphilis seroreactivityAntenatal attendeesPreterm deliveryYoung HIVAntenatal HIVHIV infectionPregnant womenSyphilis screeningRisk factorsClinical trialsUlcer treatmentHigh riskHIVAge 20African settingWomenSignificant correlatesTrialsCorrelates
2003
Developing a Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Therapeutic Research Agenda for Resource-Limited Countries: A Consensus Statement
Vermund SH, Powderly WG, Association of IDSA O. Developing a Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Therapeutic Research Agenda for Resource-Limited Countries: A Consensus Statement. Clinical Infectious Diseases 2003, 37: s4-s12. PMID: 12822127, DOI: 10.1086/375367.Peer-Reviewed Original ResearchConceptsResource-limited countriesAntiretroviral therapyResource-limited settingsDelivery of ARTImmunodeficiency syndrome careClinical Trials NetworkHealth care providersResource limited countriesHealth care practitionersHealth care advocatesHIV diseaseHIV/Consensus statementTreatment accessCare providersCare practitionersTrials NetworkART provisionCare advocatesTherapyMillions of peoplePharmaceutical expertsPatient monitoringCommunity representativesDisease
2001
Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study
Vermund SH. Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study. American Journal Of Epidemiology 2001, 153: 628-631. PMID: 11282788, DOI: 10.1093/aje/153.7.628.Peer-Reviewed Original Research
1994
NIH conference. HIV vaccine development: a progress report.
Hoth DF, Bolognesi DP, Corey L, Vermund SH. NIH conference. HIV vaccine development: a progress report. Annals Of Internal Medicine 1994, 121: 603-11. PMID: 8085693, DOI: 10.7326/0003-4819-121-8-199410150-00008.Peer-Reviewed Original ResearchConceptsVaccine candidatesAnimal modelsHuman immunodeficiency virus (HIV) infectionCytotoxic T cell responsesLarge-scale efficacy trialsInnovative vaccine candidatesImmunodeficiency virus infectionT cell responsesCorrelates of immunityEffective preventive vaccineProtective immune responseDiversity of HIVHIV vaccine researchHuman phase IPromising vaccine candidateUseful animal modelPreventive vaccineEfficacy trialsVirus infectionImmune responseVaccine researchSuch trialsPhase ITrialsHIVThe role of prevention research in HIV vaccine trials.
Vermund SH. The role of prevention research in HIV vaccine trials. AIDS Research And Human Retroviruses 1994, 10 Suppl 2: s303-5. PMID: 7865326.Peer-Reviewed Original ResearchConceptsVaccine trialsLarge-scale vaccine trialsHIV vaccine efficacy trialsPrevention researchVaccine efficacy trialsHIV vaccine trialsPrevention clinical trialsHIV prevention researchSexual transmissionClinical trialsEfficacy trialsNeedle useHIV researchInfectious diseasesBlood contaminationPotential trial sitesTrialsNational InstituteObservational researchTrial sitesSame criteriaPrevention technologiesAllergyVaccineInfection
1993
Decision making for clinical trials and prevention research: commentary on the model of Paltiel and Kaplan.
Vermund SH. Decision making for clinical trials and prevention research: commentary on the model of Paltiel and Kaplan. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1993, 6: 176-8. PMID: 8433282.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeClinical Trials as TopicCost-Benefit AnalysisDecision MakingDecision Support TechniquesHumansPolicy Making
1990
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?
Vermund S, Hoth D. How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus? Annals Of Epidemiology 1990, 1: 141-155. PMID: 1669495, DOI: 10.1016/1047-2797(90)90005-d.Peer-Reviewed Original ResearchConceptsNew therapiesHIV infectionTherapeutic trialsClinical trialsImmunodeficiency syndrome/human immunodeficiency virusVaccine developmentHuman immunodeficiency virus (HIV) infectionRecent drug trialsImmunodeficiency virus infectionDevelopment of AIDSHost immunologic responseHuman immunodeficiency virusSuch clinical parametersFuture epidemiologic researchClinical therapeutic researchNatural history studiesUse of condomsEffect of treatmentClinical research methodsVariety of treatmentsAIDS/HIV epidemicClinical courseClinical outcomesClinical parametersImmunodeficiency virus